Results 131 to 140 of about 176,246 (351)

The tacrolimus concentration‐to‐dose ratio is associated with kidney function in heart transplant recipients

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Heart transplantation (HT) is frequently complicated by chronic kidney disease, of which tacrolimus‐related nephrotoxicity is an important cause. In kidney and liver transplant recipients, fast tacrolimus metabolism (defined as a low concentration‐to‐dose [C0/D] ratio), negatively affects kidney function.
Maaike R. Schagen, Teun B. Petersen, Boris C. A. Seijkens, Jasper J. Brugts, Kadir Caliskan, Alina A. Constantinescu, Brenda C. M. de Winter, Isabella Kardys, Dennis A. Hesselink, Olivier Manintveld   +9 more
wiley   +1 more source

Deciphering the skeletal interoceptive circuitry to control bone homeostasis

BMEMat, EarlyView.
This review introduces the skeletal interoceptive circuitry, covering the ascending signals from bone tissues to the brain (sensors), the central neural circuits that integrate this information and dispatch commands (CPU), and the descending pathways that regulate bone homeostasis (effectors).
Yefeng Wu, Jiusi Guo, Zhen Chen, Fengwei Zhang, Billy Kwok Chong Chow, Zhuofan Chen, Kelvin Wai‐Kwok Yeung, Wei Qiao   +7 more
wiley   +1 more source

Value of nutritional indices in predicting survival free from pump replacement and driveline infections in centrifugal left ventricular assist devicesCentral MessagePerspective

JTCVS Open
Objective: There is a paucity of data assessing the impact of nutritional status on outcomes in patients supported with the HeartMate 3 (HM3) left ventricular assist device (LVAD).
Fabian Jimenez Contreras, MD, Bret L. Pinsker, MD, Jason N. Katz, MD, MHS, Stuart D. Russell, MD, Jacob Schroder, MD, Benjamin Bryner, MD, Alexander H. Gunn, MD, Krunal Amin, MD, Carmelo Milano, MD   +8 more
doaj  

Left Ventricular Assist Devices and Renal Ramifications

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Ajith Nair, Harveen Lamba
doaj   +1 more source

Echocardiography in left ventricular assist device

Heart Views, 2010
LVAD = Left Ventricular Assist Device; LV = Left Ventricle; LA = Left Atrium; AO = Aorta.
Rachel Hajar, Alia Albinali, Sherif M Helmy   +2 more
openaire   +4 more sources

Incorporating Clinical Examination Skills Into a Preclinical Anatomy Course: A Method for Facilitating Engagement and Interest

Clinical Anatomy, EarlyView.
ABSTRACT Anatomy instruction is enhanced when students are engaged and interested in course material, and the relevance of the subject matter to their academic success and professional careers is emphasized. We developed a learning activity for a pre‐clinical anatomy course using the clinical skills of inspection and palpation of a cadaver donor to ...
Aysha Alani, Justin O'Leary, Andrew Stieb, John P. McNamara, Michael F. Nolan   +4 more
wiley   +1 more source

Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure

European Journal of Heart Failure, Volume 24, Issue 11, Page 2131-2139, November 2022., 2022
Among patients with new‐onset or worsening heart failure (HF) undergoing optimization of HF medical therapy, dose up‐titration of angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB) therapy was associated with lower likelihood of left atrial adverse remodelling (LAAR).
Riccardo M. Inciardi, Matteo Pagnesi, Carlo M. Lombardi, Stefan D. Anker, John G. Cleland, Kenneth Dickstein, Gerasimos S. Filippatos, Chim C. Lang, Leong L. Ng, Pierpaolo Pellicori, Piotr Ponikowski, Nilesh J. Samani, Faiez Zannad, Dirk J. van Veldhuisen, Scott D. Solomon, Adriaan A. Voors, Marco Metra   +16 more
wiley   +1 more source

Percutaneous left ventricular assist devices in refractory cardiac arrest: The role of chest compressions

Resuscitation Plus, 2023
Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula, Brendan M. McCracken, Takahiro Nakashima, Nicholas L. Greer, Traci A. Cramer, Nadia R. Sutton, Kevin R. Ward, Robert W. Neumar, Mohamad Hakam Tiba, Cindy H. Hsu   +9 more
doaj  

Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence

European Journal of Heart Failure, Volume 24, Issue 11, Page 2185-2195, November 2022., 2022
Patients with heart failure and chronic kidney disease are less likely to receive and persist on guideline‐recommended medical therapies. Aim Half of heart failure (HF) patients have chronic kidney disease (CKD) complicating their pharmacological management.
Roemer J. Janse, Edouard L. Fu, Ulf Dahlström, Lina Benson, Bengt Lindholm, Merel van Diepen, Friedo W. Dekker, Lars H. Lund, Juan‐Jesus Carrero, Gianluigi Savarese   +9 more
wiley   +1 more source

Predicting Bleeding and Thrombosis Complications in Patients with Continuous Flow Left Ventricular Assist Devices [PDF]

, 2020
Background: Left ventricular assist device (LVAD) therapy has been proven to relieve heart failure symptoms and improve survival, but is not devoid of bleeding and/or thrombotic complications.
Cook, Aaron, Kuan, William, McCann, Justin McCann, Parli, Sara, Schadler, Aric, Sieg, Adam, Zacholski, Kyle   +6 more
core   +1 more source